According to Jazz Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is 9.98%. At the end of 2023 the company had an Operating Margin of 7.77%.
Year | Operating Margin | Change |
---|---|---|
2023 | 7.77% | -176.28% |
2022 | -10.19% | 179.35% |
2021 | -3.65% | -131.33% |
2020 | 11.64% | -44.62% |
2019 | 21.02% | -24.95% |
2018 | 28.00% | 2.75% |
2017 | 27.25% | -23.84% |
2016 | 35.78% | 8.75% |
2015 | 32.91% | 154.65% |
2014 | 12.92% | -63.39% |
2013 | 35.30% | 16.63% |
2012 | 30.27% | -34.06% |
2011 | 45.90% | 143.37% |
2010 | 18.86% | 52.09% |
2009 | 12.40% | -105.96% |
2008 | -208.26% | -2% |
2007 | -212.51% | 22.13% |
2006 | -174.01% | -34.71% |
2005 | -266.50% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
-129.15% | -1,394.09% | ๐ฎ๐ช Ireland | |
0.82% | -91.78% | ๐บ๐ธ USA | |
25.49% | 155.41% | ๐จ๐ญ Switzerland | |
-3.93% | -139.38% | ๐ฎ๐ฑ Israel |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.